User Guide
Eversense Medical Device 
Notification Card

Please print and give this card to your patients. Once a sensor has been placed, they should fill out the card and keep it in their wallet or purse.

Video
EVERSENSE PLACEMENT AND REMOVAL TRAINING VIDEOS

Learn how to place a new Eversense Sensor and remove a previous sensor. This video gives you step-by-step guidance, along with best practices for placement, closure and removal techniques.

Video
Setting up A Sterile Field

Watch this video to learn how to quickly and efficiently set up the required sterile field for the placement or removal of the Eversense sensor.

Video
Putting on Sterile Gloves

This instructional video demonstrates the steps necessary to put on sterile gloves prior to sensor placement or removal.

PDF
Eversense Data Management 
System (DMS) Pro

Our comprehensive, easy-to-use data management system allows patients to share their data with you through the NOW app or you can simply review information on the patient’s mobile device during an office visit.

PDF
Sample Office Procedure 
Consent Form

You’ll want to have your patient sign a consent form prior to performing a sensor placement or removal. Here’s a sample patient consent form you can use.

PDF
Patient Take Home 
Instructions

This pdf with helpful take-home instructions and tips will be useful for your patient. Download it here and give to your patient after the sensor placement.

PDF
Eversense Sensor Insertion 
and Removal Instructions

Review this step-by-step guide on how to place and remove an Eversense sensor. After appropriate training, in office sensor placement takes less than 15 minutes. Physicians, nurse practitioners and physicians’ assistants can all receive training.

Clinical Study
Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System

Learn which prescription drugs interfere with the functioning of the Eversense sensor in this report from the National Center for Biotechnology Information (NCBI.)

Clinical Study
THE PRECISE (EUROPEAN) TRIAL - 2015

The PRECISE, 180-day clinical trial was performed at 7 clinical sites in Europe and included 71 participants with Type 1 and Type 2 diabetes. Results demonstrated the safety and accuracy of the Eversense implantable CGM system and supported it as an alternative to transcutaneous CGM.

Clinical Study
THE PRECISE II (U.S.) TRIAL - 2016

The second study (Precise II) included 90 participants with Type 1 and Type 2 diabetes. It was performed in the United States and demonstrated the efficacy and safety of the Eversense CG System during 90 days of continuous sensor wear.

Clinical Study
ACCEPTABILITY OF IMPLANTABLE CGM (EUROPE) - 2017

This European study included 51 participants with Type 1 and Type 2 diabetes. It showed that the Eversense CGM with under-the-skin sensor was widely accepted by users and favorably evaluated by a high percentage of participants in the study.

Clinical Study
THE PRECISION TRIAL (U.S) - 2018

This 90-day trial included 35 adults with Type 1 and Type 2 diabetes and was designed to provide additional data on the Eversense CGM system with regard to accuracy and safety. Findings confirmed the accuracy and safety of the implantable sensor throughout the sensor life and showed a slight increase in accuracy in the very low hypoglycemic range.

Video
EVERSENSE REIMBURSEMENT FACTS AND STEP-BY-STEP PROCESS

PDF
EVERSENSE PATIENT 
EDUCATION TRAINING